Sex, thrush and bacterial vaginosis

1997 ◽  
Vol 8 (10) ◽  
pp. 603-608 ◽  
Author(s):  
P E Hay ◽  
A Ugwumadu ◽  
J Chowns

Summary: Bacterial vaginosis (BV) is the most common cause of vaginal discharge in women of childbearing age. In some women it shows a relapsing and remitting course with apparently spontaneous onset and resolution. There are intermediate patterns of vaginal flora in which lactobacilli and other species co-exist. We asked women with recurrent BV to prepare vaginal smears daily, and to record symptoms, time of menstruation, sexual activity and use of douches or medication. We Gram-stained the smears and assigned a Nugent score for BV, and noted the presence of candida, pus cells, sperm and blood. Eighteen women collected daily vaginal smears for up to 10 months. Forty months of slides were collected in total. Bacterial vaginosis arose spontaneously on 23 occasions. We saw candida arise 11 times. Bacterial vaginosis appeared after candida on 9 of these 11 episodes. We saw BV regress spontaneously 13 times. Nine of these resolutions occurred within 48 h of unprotected sexual intercourse: BV only arose on one occasion within 48 h of unprotected intercourse. The intermediate pattern was seen for up to 10 days, and occurred as BV began or resolved in some women, and sometimes resolved without developing into BV. Bacterial vaginosis arose most often in the first 7 days of a menstrual cycle, and resolved spontaneously most often in mid-cycle. In women with recurrent BV, BV arises most often around the time of menstruation and resolves spontaneously in mid-cycle. Recurrences often follow an episode of candidiasis, and BV often regresses after unprotected sexual intercourse.

Sexual Health ◽  
2018 ◽  
Vol 15 (1) ◽  
pp. 61 ◽  
Author(s):  
Kristin M. Olson ◽  
Louis J. Boohaker ◽  
Jane R. Schwebke ◽  
Stella Aslibekyan ◽  
Christina A. Muzny

Background Bacterial vaginosis (BV) is the most common cause of vaginal discharge. The objective was to compare the prevalence of BV by Nugent score among African-American women who have sex with women (WSW) and women who have sex with women and men (WSWM) compared with an age-matched group of women who have sex with men (WSM). Secondary objectives were to correlate low versus high Nugent scores with vaginal symptoms among women with BV and to correlate BV diagnosis with sexual practices. Methods: A secondary analysis of clinical and laboratory data from African-American WSW (n = 73) and WSWM (n = 68) participating in the Women’s Sexual Health Project (August 2011–October 2013) and a 3 : 1 age-matched group of African-American WSM participating in the Longitudinal Study of Vaginal Flora (August 1999–February 2002) at a sexually transmissible infection clinic (n = 423) was performed. Results:Compared with WSM, WSW and WSWM were significantly more likely to have BV based on the Nugent score (OR 2.63; 95% CI 1.55–4.48; P < 0.01 and OR 3.67; 95% CI 2.17–6.21; P < 0.01 respectively). WSW and WSWM with BV were not significantly more likely to have higher Nugent scores than WSM with BV. Among women with BV reporting symptoms, there was no significant difference in the proportion of women with low-positive versus high-positive Nugent scores. Women who participated in receptive vaginal sex (penile or digital) within the 30 days preceding study enrolment were significantly more likely to have BV (OR 2.50; 95% CI 1.57–3.63; P < 0.01). Conclusions: WSW and WSWM were significantly more likely to have BV than WSM. Further analysis of sexual practices among sexual behaviour groups of women is needed to determine their potential impact on BV rates.


2019 ◽  
Author(s):  
Filippo Murina ◽  
Ciprian Crişan ◽  
Marius Biriş ◽  
Daniela Sîrbu ◽  
Dionisio Franco Barattini ◽  
...  

ABSTRACTSeveral risk factors have been identified but the etiology and pathogenesis of Bacterial vaginosis (BV) are still not completely understood, and the recurrence rate of BV remains high despite adequate chemotherapy treatment.The primary objective of the study was to assess the effectiveness of a new vaginal medical device, which contains polycarbophil, 0.04 % lauryl glucoside, and glycerides (Polybactum®– Effik Italia), in reducing BV recurrence rate.This was a multicenter, open label, not comparative study performed in Italy and Romania. Female subjects over 18-years-old affected by recurrent BV were included. The latest episode was diagnosed by Amsel criteria 6-9 days before the start of the study and treated with vaginal metronidazole (gel 0.75% mg for 5 days or ovules 500 mg for 7 days). The recurrence was defined by at least 2 episodes in the previous 12 months. Polybactum®vaginal ovules, day 1-4-7, were started within the 12th and the 24th hr after the end of metronidazole therapy and repeated monthly for 3 cycles.The first 41 patients enrolled were evaluated for an interim analysis 6 months after the study started; 2 patients interrupted the trial, leaving 39 evaluable subjects. The recurrence rate was significantly reduced compared to previous published data (10.26% vs 40% p<0.001). In 35 patients without recurrence, the assessment of Lactobacillus vaginal flora performed by phase contrast microscopy evidenced a significant improvement form baseline (p=0.022) The Investigator global assessment of tolerability was excellent in 38 out of 39 cases.IMPORTANCEBacterial vaginosis (BV) is the most common vaginal disorder in women of childbearing age. In BV, Lactobacillus species, which are predominant in a healthy vaginal flora, are replaced by anaerobes, mainly Gardnerella vaginalis. BV is responsible for more than 60% of vulvovaginal infections and has been linked to serious, potentially life-threatening conditions, including: pelvic inflammatory disease, postoperative infections, acquisition and transmission of the human immunodeficiency virus, preterm birth, and several adverse pregnancy outcomes. Our research showed that 3 monthly cycles of Polybactum®ovules administered after one course of metronidazole vaginal therapy can reduce the rate of Bacterial vaginosis recurrence and improve the vaginal milieu, favouring the growth of vaginal lactobacillus species. Taken together our results confirm that Polibactum®is a safe and effective treatment to reduce BV recurrence rate after a first line therapy with metronidazole.


2021 ◽  
Vol 9 (C) ◽  
pp. 243-245
Author(s):  
Nugrah Santo ◽  
Muhlis Muhlis ◽  
Muji Iswanty ◽  
Idrianti Idrus ◽  
Nasrum Massi

BACKGROUND: Bartholin’s abscess is an infection of the Bartholin gland that often occurs in women of childbearing age. The prevalence of Bartholin’s abscess is 2% in the female population worldwide. Patients often complain dyspareunia with a high recurrence rate. Bacterial Vaginosis (BV) is a syndrome of changes in the vaginal ecosystem that occurs spontaneously in sexually active women. BV can contribute to the development of a Bartholin’s gland abscess. CASE REPORT: A 30-year-old woman came with the chief complaint of a 5 cm × 5 cm erythematous, tender, and mobile mass on the right side of the labia majora. In addition, the patient also experienced recurrent vaginal discharge. The patient was diagnosed with Bartholin’s abscess with BV coinfection that was successfully treated with a modified word catheter and combination of antibiotics that showed no recurrence. CONCLUSION: Combination of modified word catheter and antibiotics can be a simple yet effective way in treating Bartholin’s abscess.


F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 1761 ◽  
Author(s):  
Phillip Hay

Bacterial vaginosis is the most prevalent cause of abnormal vaginal discharge in women of childbearing age. It can have a major impact on quality of life and psychological wellbeing if frequently recurrent and strongly symptomatic. The use of molecular techniques to study the vaginal microbiome is increasing our understanding of the dynamic changes in flora that occur in health and disease. It might soon be possible to separate Gardnerella into different pathogenic and non-pathogenic species. Many groups are studying compounds that can disrupt the biofilm which is dominated by Gardnerella and Atopobium vaginae. Several studies in the last decade support the concept of bacterial vaginosis as a sexually transmitted infection.


2016 ◽  
Vol 94 (1) ◽  
pp. 75-77 ◽  
Author(s):  
Chris R Kenyon ◽  
Jozefien Buyze ◽  
Mark Klebanoff ◽  
Rebecca M Brotman

ObjectivesThe study aimed to test if there was an association between prevalent bacterial vaginosis (BV) and women reporting that their partner had other partners at the same time (partner concurrency). This association has not been assessed in a longitudinal cohort.MethodsThe Longitudinal Study of Vaginal Flora recruited a cohort of 3620 non-pregnant women aged 15–44 years who presented for routine primary healthcare at 12 clinics in Birmingham, Alabama. Behavioural questionnaires and vaginal smears were obtained quarterly for a year and BV was defined by a Nugent score 7 or higher as well as Amsel criteria. Mixed effects logistic regression was used to assess the relationship between prevalent BV and reporting that one's partner had other partners in the preceding 3–6 months time interval.ResultsNugent score prevalent BV was associated with both reporting that one's partner definitely (adjusted OR (aOR) 1.5; 95% CI 1.2 to 1.8) and possibly (aOR 1.5; 95% CI 1.2 to 1.8) engaged in partner concurrency in the preceding 3–6 months time period. Prevalent BV diagnosed by Amsel criteria was similar.ConclusionsA diagnosis of prevalent BV was associated with reporting that one's partner possibly or definitely engaged in partner concurrency.


Author(s):  
Zuhal Bulut ◽  
Deniz Gazel ◽  
Evrim Koç

Objective: Nugent scoring is accepted as the gold standard for diagnosis of bacterial vaginosis. Recently, it was reported that there could be a relationship between obesity and bacterial vaginosis. In this study, we aimed to investigate the relationship between bacterial vaginosis and obesity using Nugent score and body mass index (BMI). Method: A total of 106 fertile and sexually active patients in the childbearing age admitted to gynecology outpatient department of a state hospital in our city with symptoms of vaginal discharge and itching between May 1 and November 1, 2019 were included. Pregnant women, patients with bleeding, patients with a history of cancer, contraceptives/antibiotic/vaginal drug use within the previous three weeks, chronic disease and sexual intercourse within the last two days were excluded from the study. Anthropometric measurements and calculations of BMI were performed by the dietitian. Vaginal smears were obtained by a gynecologist and Nugent scoring was performed after Gram-staining. Results: According to Nugent score, patients were classified as having bacterial vaginosis, intermediate and normal flora. Using BMI, patients were classified as obese (36.8%), overweight (34.9%), and normal (28.3%). Nugent scoring method revealed that 33 (31.1%) of 106 patients had intermediate flora, 45 (42.5%) had bacterial vaginosis and 28 (26.4%) had normal flora. No significant relationship was found between BMI and bacterial vaginosis. Conclusion: We found no significant relationship between body mass index and bacterial vaginosis. Limited number of studies investigating the relationship between bacterial vaginosis and body mass index have contradictory results. Therefore, our study may help to close the gap on this issue.


2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Isabelle Coste ◽  
Philippe Judlin ◽  
Jean-Pierre Lepargneur ◽  
Sami Bou-Antoun

Objective. This study was performed to evaluate the efficacy and safety of a prebiotic treatment in the balance recovery of the vaginal flora in subjects previously treated for bacterial vaginosis (BV).Study Design. A randomized trial was carried out on 42 subjects with an active prebiotic group compared to a placebo group. The main evaluation criterion was the quantification of the vaginal flora measured by the Nugent score. Secondary criteria included vaginal pH and BV recurrence.Results. After 8 days of treatment, all subjects who received the prebiotic had a normal Nugent score, whereas 33% of the subjects treated with placebo had an intermediate or positive Nugent score. After 16 days of application, a normal Nugent score was maintained in all subjects treated with the prebiotic, whereas in the placebo group 24% of the subjects still had an elevated Nugent score. Moreover, the maintenance of (or reversion to) a normal flora was associated with the maintenance of (or reversion to) physiological pH values.Conclusions. The intravaginal gel treatment improves the recovery of a normal vaginal flora after the treatment of a BV episode, which should warrant a reduction in the risk of further recurrences.


2011 ◽  
Vol 139 (5-6) ◽  
pp. 402-408 ◽  
Author(s):  
Slobodanka Djukic ◽  
Natasa Opavski ◽  
Vera Mijac ◽  
Lazar Ranin

Bacterial vaginosis, earlier termed nonspecific vaginitis (anaerobic vaginosis) because of the absence of recognized pathogens, is most common vaginal syndrome of women of childbearing age affecting 15-30%. This syndrome, whose aetiology and pathogenesis remains unknown, is characterized by significant changes in the vaginal ecosystem. These changes consist of a decrease in the number of lactobacilli and a large increase in the number of anaerobic organisms. The bacteria adhere to desquamated epithelial cells with a distinctive appearance of clue cells The main complaints of women with symptomatic bacterial vaginosis include vaginal discharge and odour. However, a significant number of all women who have bacterial vaginosis deny symptoms. Bacterial vaginosis is associated with a number of gynaecologic and obstetric complications including cervicitis, cervical neoplasia, pelvic inflammatory disease, postoperative infections, and preterm labour. The diagnosis is most frequently made based on vaginal smear stained according to Gram (Nugent scoring method). Metronidazole and clindamycin are the drugs of choice for treatment of women with bacterial vaginosis. Which women should undergo treatment? According to the prevailing attitude, it should include women with symptoms. Symptomatic women with frequent relapses of bacterial vaginosisas, as a rule, have poor response to the applied therapy. To achieve better efficiency in the treatment of such women, it is necessary to have more extensive understanding of all factors in the pathogenesis of the syndrome.


2002 ◽  
Vol 13 (8) ◽  
pp. 559-563 ◽  
Author(s):  
P D J Sturm ◽  
P Moodley ◽  
G Nzimande ◽  
R Balkistan ◽  
C Connolly ◽  
...  

A vaginal tampon specimen was previously shown to be suitable for the molecular diagnosis of non-ulcerative sexually transmitted infections (STIs). Different tampon fluid preparations were evaluated for the diagnosis of bacterial vaginosis (BV). Women with pregnancy related problems were enrolled. Two observers evaluated the different tampon fluid preparations and vaginal smears collected during speculum examination using the Nugent score. Using the Amsel criteria, 21% of the 84 women enrolled were diagnosed with BV. Results of the tampon fluid preparations and vaginal smears showed excellent agreement for both observers (Spearman >0.80). The overall sensitivity and specificity was 91.7% (95% CI: 81.6-96.5) and 79.3% (95% CI: 67.2-87.8), respectively, using the Amsel criteria as reference standard. The tampon provides a specimen for the combined diagnosis of non-ulcerative STIs and BV. This non-invasively collected specimen may facilitate self-initiated testing and population-based studies as well as longitudinal studies that are necessary to gain insight in the epidemiology of BV related to STIs and HIV.


2019 ◽  
Vol 7 (1) ◽  
pp. 9
Author(s):  
Anik Sri Purwanti ◽  
Sumarno Sumarno ◽  
Bambang Rahardjo ◽  
Sri Winasih ◽  
Sri Poeranto

Woman’s reproductive tract often has problems, especially in women of childbearing age. One of them is Bacterial Vaginosis is a clinical condition that occurs a lot. BV infection is a polymicrobial infection caused by a decrease in the amount of Lactobaclilus with anaerobic bacteria that increases excessively. Alternative treatment for BV is given by using the results hydrolysates of konjac plant extracted in dosage forms Glucomannan Hydrolysates (GMH) containing glucose and mannose prebiotic which can support the growth development of Lactobacillus in the vaginal mucosa. This study was to determine the effect of Glucomannan Hydrolisates (GMH) + Metronidazole on levels of IL 23 cytokines in BV of reproductive age women. The method of this study used the True Experimental design with the type of research The randomized pretest-posttest was in vivo. The subjects selected in this study design used Randomized techniques. A sample of 7 people WUS with BV given GMH 300mg + Metronidazole 1000 mg for 9 days of use, To assess the levels of cytokine IL 23 using the ELISA method. Data analysis using a ratio scale was analyzed using the metric statistical test, normality test using Shapiro-Wilk test and comparative test using Repeated Measure ANOVA. The overall results of the analysis showed that the combination of GMH and Antibiotics Metronidazole could significantly increase the levels of cytokine IL 23 compared to other therapies to treat bacterial vaginosis in women of childbearing age


Sign in / Sign up

Export Citation Format

Share Document